Protection by flavonoids against anthracycline cardiotoxicity: from chemistry to clinical trials.
about
Inhibition of polymorphic human carbonyl reductase 1 (CBR1) by the cardioprotectant flavonoid 7-monohydroxyethyl rutoside (monoHER)Cardiomyocyte death in doxorubicin-induced cardiotoxicityAnticancer activity of released doxorubicin from a folate-mediated polyelectrolyte complex.Antitumor efficacy of doxorubicin released from crosslinked nanoparticulate chondroitin sulfate/chitosan polyelectrolyte complexes.Associations between flavonoids and cardiovascular disease incidence or mortality in European and US populations.Protective effect of guggulsterone against cardiomyocyte injury induced by doxorubicin in vitroSynthesis, structure-activity relationship studies, and antibacterial evaluation of 4-chromanones and chalcones, as well as olympicin A and derivativesTotal Flavonoids from Clinopodium chinense (Benth.) O. Ktze Protect against Doxorubicin-Induced Cardiotoxicity In Vitro and In Vivo.Iron chelators with topoisomerase-inhibitory activity and their anticancer applications.Doxorubicin Cardiotoxicity and Cardiac Function Improvement After Stem Cell Therapy Diagnosed by Strain Echocardiography.Doxorubicin induced heart failure: Phenotype and molecular mechanisms.Recent advances in protection against doxorubicin-induced toxicity.Animal models in studies of cardiotoxicity side effects from antiblastic drugs in patients and occupational exposed workersOxidative stress and vascular function: implications for pharmacologic treatments.Flavonoids in prevention of diseases with respect to modulation of Ca-pump function.The flavonoid monoHER prevents monocrotaline-induced hepatic sinusoidal injury in rats.The semisynthetic flavonoid monoHER sensitises human soft tissue sarcoma cells to doxorubicin-induced apoptosis via inhibition of nuclear factor-κB.Predictive Modeling of Antioxidant Coumarin Derivatives Using Multiple Approaches: Descriptor-Based QSAR, 3D-Pharmacophore Mapping, and HQSAR.Protective effect of p-coumaric acid against doxorubicin induced toxicity in H9c2 cardiomyoblast cell lines.Mitochondria-targeted cardioprotection in aldosteronism.The anthracyclines: when good things go bad.Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage.Boswellic acids synergize antitumor activity and protect against the cardiotoxicity of doxorubicin in mice bearing Ehrlich's carcinoma.Quercetin Reverses Altered Energy Metabolism in the Heart of Rats Receiving Adriamycin Chemotherapy.The decrease of NAD(P)H:quinone oxidoreductase 1 activity and increase of ROS production by NADPH oxidases are early biomarkers in doxorubicin cardiotoxicity.
P2860
Q24336929-AF79F792-438B-471E-AAFF-60DF97D79C99Q33604134-E3FC92FC-DDE1-4521-8349-656DFD53250CQ33631805-8B8B60FC-5B47-4B95-83B3-96B4C3A61913Q33832548-84D95520-E139-4C12-9397-F82D2C18AFE6Q34033401-F6107B47-4914-45C9-B7EA-56AE6D6B9581Q34392758-B855B039-521E-46D8-A383-89F2F5D46B07Q34394121-26564265-F04A-4DA4-8E7B-5DBD01B5777FQ35136498-214B7FC5-32F3-486C-BC6B-2E444ED4CC5FQ36568915-226570F6-7530-4751-9BC1-EB52FE7B1636Q36650772-877F8DA9-3230-4155-9384-54F88E3EEB3AQ36912561-198712EB-80EB-4DDE-993F-4FBFA1B89ED6Q37338134-ED87A5BC-D9B1-484A-8EC4-31DBFFDA8A66Q37631325-4F89BC01-9FB2-4BB6-AA28-9F933012806BQ37738027-A9A66466-A80C-44EF-980C-9093091494D8Q38861794-82CF149F-FC09-4AD2-976C-F7084295FF06Q39404639-2E77D8C6-F026-4888-93B4-204FD16C3556Q39606069-C7541110-E401-4FC2-8626-17240C69E21BQ39625302-CC6131D7-B983-4BB7-9B48-ACBF88A160E9Q41680030-EEFEBBC2-C6EF-4E06-99D9-B21F0F5089BAQ41985174-0983204E-17C0-4A24-BE59-7B51F32994D8Q42163160-E8D404FB-9DED-4F00-9C34-BE7A3C57C86AQ46146946-8C6F275D-41ED-4466-BF6B-64A4371E91BBQ46210824-E0EE821F-394D-4534-8F98-0AAE3080D880Q46827590-E36069B3-B720-44C8-8852-4F9FF950A23FQ46934674-E432B22F-3EFA-4CE2-AC4E-6231FFD7C41E
P2860
Protection by flavonoids against anthracycline cardiotoxicity: from chemistry to clinical trials.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Protection by flavonoids again ...... chemistry to clinical trials.
@en
type
label
Protection by flavonoids again ...... chemistry to clinical trials.
@en
prefLabel
Protection by flavonoids again ...... chemistry to clinical trials.
@en
P2093
P1476
Protection by flavonoids again ...... chemistry to clinical trials.
@en
P2093
Anna M E Bruynzeel
Wim J F Van der Vijgh
P2860
P2888
P304
P356
10.1007/S12012-007-0018-0
P50
P577
2007-01-01T00:00:00Z